Digestive and Liver Disease

1.0(top 50%)

impact factor

17.8K(top 1%)

papers

108.5K(top 5%)

citations

105(top 5%)

h-index

1.0(top 50%)

impact factor

19.4K

all documents

114.2K

doc citations

155(top 5%)

g-index

Top Articles

#	Title	Journal	Year	Citations
1	Hepatic steatosis index: A simple screening tool reflecting nonalcoholic fatty liver disease	Digestive and Liver Disease	2010	896
2	Nonalcoholic fatty liver disease: A precursor of the metabolic syndrome	Digestive and Liver Disease	2015	551
3	The changing pattern of epidemiology in hepatocellular carcinoma	Digestive and Liver Disease	2010	465
4	From the metabolic syndrome to NAFLD or vice versa?	Digestive and Liver Disease	2010	406
5	European experts consensus statement on cystic tumours of the pancreas	Digestive and Liver Disease	2013	406
6	Actinobacteria: A relevant minority for the maintenance of gut homeostasis	Digestive and Liver Disease	2018	377
7	Bacterial infection in patients with advanced cirrhosis: a multicentre prospective study	Digestive and Liver Disease	2001	368
8	Epidemiological modifiers of non-alcoholic fatty liver disease: Focus on high-risk groups	Digestive and Liver Disease	2015	368
9	Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with nonalcoholic fatty liver disease (NAFLD)	Digestive and Liver Disease	2008	361
10	The bile acid TGR5 membrane receptor: From basic research to clinical application	Digestive and Liver Disease	2014	340
11	Liver fibrosis: from the bench to clinical targets	Digestive and Liver Disease	2004	294
12	Increased liver echogenicity at ultrasound examination reflects degree of steatosis but not of fibrosis in asymptomatic patients with mild/moderate abnormalities of liver transaminases	Digestive and Liver Disease	2002	288
13	Alterations in the colonic flora and intestinal permeability and evidence of immune activation in chronic constipation	Digestive and Liver Disease	2005	284
14	The role of bright liver echo pattern on ultrasound B-mode examination in the diagnosis of liver steatosis	Digestive and Liver Disease	2006	276
15	Herbal medicine in the treatment of liver diseases	Digestive and Liver Disease	2007	266
16	OLGA staging for gastritis: A tutorial	Digestive and Liver Disease	2008	258
17	Effects of n-3 polyunsaturated fatty acids in subjects with nonalcoholic fatty liver disease	Digestive and Liver Disease	2008	254
18	AISF position paper on nonalcoholic fatty liver disease (NAFLD): Updates and future directions	Digestive and Liver Disease	2017	254
19	Resveratrol improves insulin resistance, glucose and lipid metabolism in patients with non-alcoholic fatty liver disease: A randomized controlled trial	Digestive and Liver Disease	2015	251
20	Role of faecal calprotectin as non-invasive marker of intestinal inflammation	Digestive and Liver Disease	2003	247
21	Gastric cancer exosomes promote tumour cell proliferation through PI3K/Akt and MAPK/ERK activation	Digestive and Liver Disease	2009	246
22	Alpha-SMA expression in hepatic stellate cells and quantitative analysis of hepatic fibrosis in cirrhosis and in recurrent chronic hepatitis after liver transplantation	Digestive and Liver Disease	2005	245
23	Small bowel adenocarcinoma: Epidemiology, risk factors, diagnosis and treatment	Digestive and Liver Disease	2014	245
24	The human gut microbiota and virome: Potential therapeutic implications	Digestive and Liver Disease	2015	226
25	Extrahepatic manifestations of Hepatitis C Virus infection: A general overview and guidelines for a clinical approach	Digestive and Liver Disease	2007	222
26	Non-alcoholic fatty liver disease pathogenesis: The present and the future	Digestive and Liver Disease	2009	222
27	Extrahepatic manifestations of chronic hepatitis C virus infection	Digestive and Liver Disease	2014	218
28	Role of spleen enlargement in cirrhosis with portal hypertension	Digestive and Liver Disease	2002	208
29	Bacterial supplementation in the irritable bowel syndrome. A randomised doubleblind placebo-controlled crossover study	Digestive and Liver Disease	2000	206
30	A pilot trial of fenofibrate for the treatment of non-alcoholic fatty liver disease	Digestive and Liver Disease	2008	206
31	Variation in human intestinal microbiota with age	Digestive and Liver Disease	2002	203
32	Practice guidelines for the diagnosis and management of nonalcoholic fatty liver disease	Digestive and Liver Disease	2010	202
33	Prophylaxis and treatment of hepatitis B in immunocompromised patients	Digestive and Liver Disease	2007	197
34	Questions and answers on the role of faecal calprotectin as a biological marker in inflammatory bowel disease	Digestive and Liver Disease	2009	195
35	Altered molecular signature of intestinal microbiota in irritable bowel syndrome patients compared with healthy controls: A systematic review and meta-analysis	Digestive and Liver Disease	2017	194
36	Forecasting the morbidity and mortality associated with prevalent cases of pre-cirrhotic chronic hepatitis C in the United States☆☆☆	Digestive and Liver Disease	2011	189
37	Functional food concept and its application to prebiotics	Digestive and Liver Disease	2002	175
38	Extraintestinal manifestations of inflammatory bowel disease	Digestive and Liver Disease	2008	171
39	Malignancies and mortality in patients with coeliac disease and dermatitis herpetiformis: 30-year population-based study	Digestive and Liver Disease	2006	170
40	Drug-eluting beads versus conventional chemoembolization for the treatment of unresectable hepatocellular carcinoma: A meta-analysis	Digestive and Liver Disease	2016	168
41	Bile acids permeabilize the blood brain barrier after bile duct ligation in rats via Rac1-dependent mechanisms	Digestive and Liver Disease	2014	167
42	Peppermint oil (Mintoil®) in the treatment of irritable bowel syndrome: A prospective double blind placebo-controlled randomized trial	Digestive and Liver Disease	2007	163
43	Gut microbiota and probiotics in chronic liver diseases	Digestive and Liver Disease	2011	163
44	Systematic review and meta-analysis of observational studies on the prevalence of fractures in coeliac disease	Digestive and Liver Disease	2008	159
45	Cholangiocarcinoma: Update and future perspectives	Digestive and Liver Disease	2010	158
46	Epidemiology of inflammatory bowel diseases: New insights from a French population-based registry (EPIMAD)	Digestive and Liver Disease	2013	157
47	Ultrastructural mucosal alterations and increased intestinal permeability in non-celiac, type I diabetic patients	Digestive and Liver Disease	2004	156
48	Wireless capsule video endoscopy compared to barium follow-through and computerised tomography in patients with suspected Crohn’s disease—final report	Digestive and Liver Disease	2004	156
49	Hepatocellular carcinoma in non-cirrhotic liver: A reappraisal	Digestive and Liver Disease	2010	155
50	Position paper of the Italian Association for the Study of the Liver (AISF): The multidisciplinary clinical approach to hepatocellular carcinoma	Digestive and Liver Disease	2013	155

Scientometrics

Overviews

Citing Bodies

Digestive and Liver Disease

Top Articles